SCHEMBL19164584

SCHEMBL19164584

Cc1ccc(-c2nc(-c3ccc(C#N)cc3)nc(-c3ccc4c(c3)-c3ccccc3-c3ccccc3C43c4ccccc4-c4ccccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.40
▸ ABCG2 Q9UNQ0 8/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ ABCB1 P08183 5/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ABCC1 P33527 2/20 0.35
▸ KDM1A O60341 1/20 0.35
▸ ADORA2B P29275 1/20 0.34
▸ GRM2 Q14416 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SCN10A Q9Y5Y9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19172959 0.94 PDK2 (0.44) PDK2ABCG2ABCB1KDM4EABCC1
SCHEMBL19164576 0.93 KDM4E (0.42) PDK2ABCG2ALDH1A1CYP2A6NPSR1
SCHEMBL19164552 0.91 ABCG2 (0.46) PDK2ABCG2ALDH1A1ABCB1KDM4E
SCHEMBL19164391 0.90 ABCG2 (0.45) PDK2ABCG2ALDH1A1ABCB1ABCC1
SCHEMBL12345515 0.89 PDK2 (0.44) PDK2ABCG2ALDH1A1CYP2A6ABCB1
SCHEMBL21923480 0.88 PDK2 (0.42) PDK2ABCG2ALDH1A1NPSR1KDM4E
SCHEMBL12134947 0.88 PDK2 (0.45) PDK2ABCG2ALDH1A1CYP2A6ABCB1
SCHEMBL19164313 0.88 ABCG2 (0.40) PDK2ABCG2ABCB1HPGD
SCHEMBL19172916 0.86 PDK2 (0.45) PDK2ABCG2ALDH1A1ABCB1KDM4E
SCHEMBL19171609 0.86 PDK2 (0.50) PDK2ABCG2ABCB1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 PDK2 1279/4885ABCG2 2072/4885ALDH1A1 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback